title: Angiotensin converting enzyme inhibitors and angiotensin II antagonists as therapy in chronic liver disease.
authors.affiliation: Liver Transplantation and Hepatobiliary Medicine Royal Free Hospital, London, UK.
authors.forename: J
authors.initials: J
authors.lastname: Vlachogiannakos
authors.forename: A K
authors.initials: AK
authors.lastname: Tang
authors.forename: D
authors.initials: D
authors.lastname: Patch
authors.forename: A K
authors.initials: AK
authors.lastname: Burroughs
mesh_terms: D000804:Angiotensin II / Q000037:antagonists & inhibitors / Q000627:therapeutic use*; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002908:Chronic Disease; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006801:Humans; D006975:Hypertension, Portal / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D008103:Liver Cirrhosis / Q000150:complications* / Q000188:drug therapy / Q000378:metabolism; D016032:Randomized Controlled Trials as Topic; D011945:Receptors, Angiotensin / Q000627:therapeutic use*; D012964:Sodium / Q000378:metabolism
chemical_list: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D011945:Receptors, Angiotensin; D000804:Angiotensin II; D012964:Sodium